These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32089480)

  • 21. Impact of serum albumin levels on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Heart Vessels; 2017 Sep; 32(9):1085-1092. PubMed ID: 28429111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein(a) levels are associated with coronary severity but not with outcomes in Chinese patients underwent percutaneous coronary intervention.
    Xu N; Tang XF; Yao Y; Jia SD; Liu Y; Zhao XY; Chen J; Gao Z; Yang YJ; Gao RL; Xu B; Yuan JQ
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):265-273. PubMed ID: 31740238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Plasma Lipoprotein(a) With Long-Term Adverse Events in Patients With Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
    Xu N; Tang XF; Yao Y; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Am J Cardiol; 2018 Dec; 122(12):2043-2048. PubMed ID: 30477725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting.
    Ezhov MV; Safarova MS; Afanasieva OI; Kukharchuk VV; Pokrovsky SN
    Atherosclerosis; 2014 Aug; 235(2):477-82. PubMed ID: 24952151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention.
    Li ZG; Li G; Zhou YL; Chen ZJ; Yang JQ; Zhang Y; Sun S; Zhong SL
    Lipids Health Dis; 2013 Aug; 12():127. PubMed ID: 23978127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated Lipoprotein(a) has Incremental Prognostic Value in Type 2 Diabetic Patients with Symptomatic Coronary Artery Disease.
    Kwon SW; Kim JY; Sung JM; Yoon YW; Rhee JH; Lee BK; Jung YH; Kim KH; Cha JJ; Park JK; Choi EY; Hong BK; Rim SJ; Kwon HM
    J Atheroscler Thromb; 2015; 22(5):527-34. PubMed ID: 25445892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Lipoprotein (a) Levels on Long-term Cardiovascular Outcomes in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.
    Gao S; Ma W; Huang S; Lin X; Yu M
    Am J Cardiol; 2021 Aug; 152():34-42. PubMed ID: 34130824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical impact of serum albumin in coronary artery disease patients with preserved renal function.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Suwa S; Daida H
    Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):285-290. PubMed ID: 29289574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impacts of diabetes status and lipoprotein(a) levels in patients with ST-segment elevation myocardial infarction: a prospective cohort study.
    Li N; Zhou J; Chen R; Zhao X; Li J; Zhou P; Liu C; Chen Y; Wang Y; Song L; Yan S; Zhao H; Yan H
    Cardiovasc Diabetol; 2023 Jun; 22(1):151. PubMed ID: 37365608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Combined C-Reactive Protein and High-Density Lipoprotein Cholesterol Levels on Long-Term Outcomes in Patients With Coronary Artery Disease After a First Percutaneous Coronary Intervention.
    Ogita M; Miyauchi K; Tsuboi S; Shitara J; Endo H; Wada H; Doi S; Naito R; Konishi H; Dohi T; Kasai T; Tamura H; Okazaki S; Suwa S; Daida H
    Am J Cardiol; 2015 Oct; 116(7):999-1002. PubMed ID: 26243577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A large cohort study.
    Cui K; Yin D; Zhu C; Yuan S; Wu S; Feng L; Dou K
    Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1670-1680. PubMed ID: 35525680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of lipoprotein(a) with long-term mortality following coronary angiography or percutaneous coronary intervention.
    Feng Z; Li HL; Bei WJ; Guo XS; Wang K; Yi SX; Luo DM; Li XD; Chen SQ; Ran P; Chen PY; Islam SMS; Chen JY; Liu Y; Zhou YL
    Clin Cardiol; 2017 Sep; 40(9):674-678. PubMed ID: 28444976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of elevated baseline bilirubin caused by preadmission statin use with cardiovascular prognosis in patients undergoing elective percutaneous coronary intervention.
    Zhu Y; Li D; Li J; Wang Y; Chen Z; Lv Q; Fu G; Zhang W
    Sci Rep; 2024 Sep; 14(1):20451. PubMed ID: 39227723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention.
    Chikata Y; Iwata H; Miyosawa K; Naito R; Koike T; Moriya S; Yasuda H; Funamizu T; Doi S; Endo H; Wada H; Ogita M; Dohi T; Kasai T; Isoda K; Okazaki S; Miyauchi K; Minamino T
    Cardiovasc Diabetol; 2024 Mar; 23(1):114. PubMed ID: 38555431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the prognostic nutritional index and long-term clinical outcomes in patients with stable coronary artery disease.
    Wada H; Dohi T; Miyauchi K; Jun S; Endo H; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    J Cardiol; 2018 Aug; 72(2):155-161. PubMed ID: 29496336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute Myocardial Infarction Registry.
    Kim YH; Her AY; Jeong MH; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1264-1275. PubMed ID: 30474346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma lipoprotein(a) predicts major cardiovascular events in patients with chronic kidney disease who undergo percutaneous coronary intervention.
    Konishi H; Miyauchi K; Tsuboi S; Ogita M; Naito R; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
    Int J Cardiol; 2016 Feb; 205():50-53. PubMed ID: 26710333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
    Fukase T; Dohi T; Koike T; Yasuda H; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
    ESC Heart Fail; 2022 Feb; 9(1):545-554. PubMed ID: 34811932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
    Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
    J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between Lipoprotein(a) concentration and adverse cardiac events in patients with coronary artery disease: An observational cohort study.
    Amin N; Devasia T; Kamath SU; Paramasivam G; Shetty PN; Singh A; Prakash N S G
    Indian Heart J; 2024; 76(3):197-201. PubMed ID: 38871220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.